All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
VERVE THERAPEUTICS, INC. Last Reported: 5/31/2024 Stock Symbol: VERV

Business Address

201 BROOKLINE AVENUE
SUITE 601
BOSTON , MA US 02215

Mailing Address

201 BROOKLINE AVENUE
SUITE 601
BOSTON , MA US 02215
Phone Number: (978) 501-3026 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 12/31/2018
Cash and Cash Equivalents $144,200,000.00 $206,180,000.00 $78,370,000.00 $70,042,000.00 $83,746,000.00 $115,412,000.00 $277,019,000.00 $72,889,000.00 $91,420,000.00 $148,134,000.00 $387,446,000.00 -- $8,993,000.00 $11,859,000.00 $20,931,000.00 -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $8,192,000.00 $8,102,000.00 $9,890,000.00 $8,497,000.00 $7,696,000.00 $7,339,000.00 $9,991,000.00 $5,083,000.00 $5,531,000.00 $5,227,000.00 $1,940,000.00 -- $1,854,000.00 -- -- -- -- --
Total Current Assets $620,326,000.00 $637,949,000.00 $498,261,000.00 $473,066,000.00 $517,787,000.00 $563,159,000.00 $561,630,000.00 $298,644,000.00 $328,830,000.00 $394,437,000.00 $419,564,000.00 -- $73,966,000.00 -- -- -- -- --
Property Plant and Equipement $21,024,000.00 $22,505,000.00 $20,803,000.00 $21,252,000.00 $21,053,000.00 $18,778,000.00 $15,159,000.00 $12,354,000.00 $11,132,000.00 $6,574,000.00 $6,417,000.00 -- $3,984,000.00 -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $2,706,000.00 $2,165,000.00 $1,528,000.00 $1,223,000.00 $709,000.00 $585,000.00 $410,000.00 $7,193,000.00 $2,702,000.00 $2,294,000.00 $74,000.00 -- -- -- -- -- -- --
Total Assets $732,357,000.00 $752,688,000.00 $612,407,000.00 $589,131,000.00 $634,376,000.00 $679,223,000.00 $673,355,000.00 $324,267,000.00 $349,241,000.00 $410,877,000.00 $426,518,000.00 -- $78,413,000.00 -- -- -- -- --
Accounts Payable $3,049,000.00 $6,636,000.00 $1,054,000.00 $3,146,000.00 $3,372,000.00 $2,424,000.00 $465,000.00 $6,320,000.00 $2,438,000.00 $3,579,000.00 $1,530,000.00 -- $36,000.00 -- -- -- -- --
Accrued Liabilities $16,552,000.00 $20,178,000.00 $23,403,000.00 $19,839,000.00 $18,996,000.00 $20,767,000.00 $19,649,000.00 $18,620,000.00 $10,933,000.00 $8,127,000.00 $6,967,000.00 -- $7,189,000.00 -- -- -- -- --
Total Current Liabilities $149,288,000.00 $153,186,000.00 $152,038,000.00 $123,909,000.00 $124,900,000.00 $128,291,000.00 $125,412,000.00 $27,934,000.00 $17,851,000.00 $25,942,000.00 $21,122,000.00 -- $17,162,000.00 -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $1,176,526,000.00 $1,143,453,000.00 $956,855,000.00 $916,109,000.00 $905,863,000.00 $895,801,000.00 $851,954,000.00 $555,184,000.00 $549,089,000.00 $540,402,000.00 $538,109,000.00 -- $2,616,000.00 -- -- -- -- --
Accumulated Other Comprehensive Loss $-500,000.00 $272,000.00 $-597,000.00 $-754,000.00 $-237,000.00 $-694,000.00 $-920,000.00 $-938,000.00 $-732,000.00 $-2,000.00 $3,000.00 -- $8,000.00 -- -- -- -- --
Accumulated Deficit $-593,041,000.00 $-544,305,000.00 $-495,953,000.00 $-450,195,000.00 $-396,212,000.00 $-344,237,000.00 $-303,152,000.00 $-257,962,000.00 $-217,016,000.00 $-155,513,000.00 $-132,764,000.00 -- $-66,536,000.00 -- -- -- -- --
Total Stockholders' Equity $583,069,000.00 $599,502,000.00 $460,369,000.00 $465,222,000.00 $509,476,000.00 $550,932,000.00 $547,943,000.00 $296,333,000.00 $331,390,000.00 $384,935,000.00 $405,396,000.00 $-76,431,000.00 $-63,909,000.00 $-40,822,000.00 $-32,059,000.00 $-24,560,000.00 $-19,553,000.00 $-1,484,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $732,357,000.00 $752,688,000.00 $612,407,000.00 $589,131,000.00 $634,376,000.00 $679,223,000.00 $673,355,000.00 $324,267,000.00 $349,241,000.00 $410,877,000.00 $426,518,000.00 -- $78,413,000.00 -- -- -- -- --

Statement of Operations

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 12/31/2018
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $48,376,000.00 $184,946,000.00 $138,135,000.00 $47,260,000.00 $47,110,000.00 $130,095,000.00 $92,811,000.00 $33,125,000.00 $24,490,000.00 $42,263,000.00 $24,768,000.00 -- -- $19,795,000.00 $5,654,000.00 -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $62,539,000.00 $234,882,000.00 $55,451,000.00 $120,339,000.00 $59,663,000.00 $167,628,000.00 $44,789,000.00 $42,192,000.00 $31,925,000.00 $23,502,000.00 $31,025,000.00 -- -- $8,972,000.00 $14,055,000.00 -- -- --
Loss from Operations $-56,844,000.00 $-223,124,000.00 $-169,176,000.00 $-116,842,000.00 $-58,259,000.00 $-165,687,000.00 $-117,977,000.00 $-42,192,000.00 $-31,925,000.00 $-54,527,000.00 $-31,025,000.00 -- -- $-23,027,000.00 $-14,055,000.00 -- -- --
Loss Before Income Taxes $-48,630,000.00 $-199,793,000.00 $-45,691,000.00 $-53,807,000.00 -- $-157,334,000.00 -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.59 $-3.12 $-0.72 $-1.71 $-0.84 $-2.91 $-2.26 -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 83,132,960 64,175,137 63,211,849 61,871,158 61,787,403 54,023,653 51,516,037 -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.59 $-3.12 $-2.43 $-1.71 $-0.84 $-2.91 $-0.79 -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 83,132,960 64,175,137 63,211,849 61,871,158 61,787,403 54,023,653 57,207,125 -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 -- 255,000,000 -- -- -- -- --
Common Stock Shares Outstanding 83,819,862 81,969,693 63,737,089 62,064,279 61,863,010 61,730,816 60,443,175 48,709,652 48,655,241 48,081,404 47,946,996 -- 2,585,789 -- -- -- -- --
Common Stock Value $84,000.00 $82,000.00 $64,000.00 $62,000.00 $62,000.00 $62,000.00 $61,000.00 $49,000.00 $49,000.00 $48,000.00 $48,000.00 -- $3,000.00 -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com